Is VistaGen The Next Big Winner In CNS?
I’ve been a stock analyst for a pretty long time – going on 16 years now. I’ve picked some big winners and some big losers. One thing I noticed, I seem to have better luck in CNS disorders than say, wound care! Acadia Pharmaceuticals, Auspex Pharma, Neurocrine Bio, and Cynapsus Therapeutics were all small-cap biopharma…